Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Sep 3, 2026 · 4:00 PM EDT

Revium Rx (RVRC) Price to Book (2024 - 2026)

Revium Rx's (RVRC) quarterly Price to Book came in at 18.38 in Q2 2026, up 1021.22% year-over-year from 1.64 in Q2 2025, and up 300.41% quarter-over-quarter from 4.59 in Q4 2025.

Analysis

Revium Rx (RVRC) Price to Book (2024 - 2026) Analysis & Trends

Revium Rx has disclosed Price to Book across 3 years of filings, most recently posting 18.38 for Q2 2026.

  • In Q2 2026, Price to Book rose 1021.22% year-over-year to 18.38; the TTM figure through Jun 2026 stood at 18.38 (up 1021.22% YoY), while the FY2025 annual figure was 4.59, up 272.3% from the prior year.
  • Price to Book came in at 18.38 for Q2 2026 at Revium Rx, up from 4.59 in the prior quarter.
  • In the past five years, Price to Book ranged from a high of 18.38 in Q2 2026 to a low of 1.23 in Q4 2024.
  • Average Price to Book over 3 years is 6.46, with a median of 3.11 recorded in 2025.
  • Year-over-year, Price to Book jumped 272.3% in 2025 and soared 1021.22% in 2026.
  • Over 3 years, Price to Book stood at 1.23 in 2024, then surged by 272.3% to 4.59 in 2025, then surged by 300.41% to 18.38 in 2026.
  • Per Business Quant data, the three most recent Price to Book figures were 18.38 in Q2 2026, 4.59 in Q4 2025, and 1.64 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Revium Rx 86.84 Mn 85.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.38
Dec 31, 2025 4.59
Jun 30, 2025 1.64
Dec 31, 2024 1.23